Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021

BACKGROUND: Whether immunocompromising conditions affect the immunogenicity of COVID-19 booster vaccination remains a concern, which impedes the vaccination campaign in people most vulnerable to COVID-19-associated morbidity and mortality. We aimed to evaluate the effect of immune dysfunction on imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kuan-Yin, Hsieh, Ming-Ju, Chang, Sui-Yuan, Ieong, Si-Man, Cheng, Chien-Yu, Sheng, Wang-Huei, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428601/
https://www.ncbi.nlm.nih.gov/pubmed/36089471
http://dx.doi.org/10.1016/j.jfma.2022.08.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428601/
https://www.ncbi.nlm.nih.gov/pubmed/36089471
http://dx.doi.org/10.1016/j.jfma.2022.08.017

Ejemplares similares